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The antigen receptor (TCR) on effectorT lymphocytes hasbeen characterized
as an a# chain heterodimer that is associated with the CD3 (T3) complex on the
cell surface (1) . Recently, a second CD3-associated heterodimer, composed of a
y gene product and a putative S gene product, has been identified on a subset of
human lymphocytes (2, 3) human thymocytes (4), and murine thymocytes (5) .
Because # and y chain mRNA, in contrast to a chain mRNA transcripts, are
abundant in immature murine thymocytes (6, 7) it was hypothesized that such
thymocytes could express #y receptors that are replaced by a# receptors after
translation of a chain mRNA (6, 7) . However, no evidence exists that # and y
protein can be synthesized by a single cell . In this reportwe show that the human
T cell line PEER, which expresses a CD3 associated TCR y chain on the cell
surface (8, 9), synthesizes a 38 kD 0 chain product that associates intracellularly
with CD3 . However, this CD3-TCR# complex is not found on the cell surface,
presumably because no a chain protein can be synthesized (8) . We conclude that
# and y proteins can be produced within the same cell and that they can
independently form CD3-TCR# and CD3-TCRy chain complexes . However, we
could find no evidence for CD3-TCR #y complexes in this cell line .
Materials and Methods
BriefDefinitive Report
Radiolabeling and Immunoprecipitation.
￿
Cells were surface labeled with "I as described
previously (10) . For biosynthetic labeling, 5-10 x 10' cells were washed twice with
PBS/1% FCS and subsequently resuspended in 25-50 ml Met/Cys-free RPMI 1640 (Flow
Laboratories, McLean, VA) supplemented with 20 mM Hepes, 5% FCS, and 0.5 mCi
each of [s 5S]Met and [ssS]Cys . After a 5-h labeling period, the cells were harvested and
lysed in lysis buffer containing 0 .5% NP-40 or I% digitonin as described previously (10) .
After 15 min at 0°C, the lysates were spun for 15 min at 13,000 g . Supernatants were
precleared for 16 h at 4°C with 50,1 normal rabbit serum and 100 II protein A-agarose
beads (PAA beads) (BRL, Bethesda, MD) . After removal of the PAA beads by centrifuga-
tion, specific precipitations were carried out by adding 5 jl of antiserum to 50-100 JAI of
lysate . After 60 min, 5 u1 of PAA beads were added for a second 60-min incubation .
Subsequently the beads were washed four or five times with lysis buffer . Immunoprecip-
itates were analyzed on 12% SDS-PAGE gels under reducing conditions with subsequent
autoradiography .
Antisera.
￿
Antisera specific for TCR # chains (anti-#), TCRy chains (anti- ,y), and CD36
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FIGURE 1 .
￿
Analysis of CD3-associated molecules and TCR ß chain expression on surface
iodinated or biosynthetically labeled PEER cells . A, Cells were surface iodinated and lysed in
either NP-40 (lanes 1 and 2) or digitonin lysis buffer (lanes 3 and 4) . Precipitations were
carried out with normal rabbit serum (lanes 1 and 3), anti-TCR y chain antiserum (lane 2) and
anti-CD3 3 antiserum (lane 4). B, Cells were cell-surface iodinated ("I) or biosynthetically
labeled ("S), lysed in I% digitonin buffer, and immunoprecipitations were carried out with
normal rabbit serum (C, lanes 1), anti-ß serum (lanes 2) and anti-CD3á serum (lanes 3) .
(anti-CD3S) chains were raised by immunization of rabbits with specific COOH-terminal
peptides as described previously (10) .
Rabiolabeling and Purification of Proteins for Subsequent NH2-Terminal Amino Acid Se-
quence Analysis. Proteins for amino acid sequence analysis were isolated from 2 x 10'
PEER cells biosynthetically labeled with 1 mCi [s5S]Met and 5 mCi [sH]Leu in 50 ml
Met/Leu-free RPMI 1640 (Gibco, Grand Island, NY) supplemented with 5% FCS and 20
mM Hepes for 5 h . After washing twice in RPMI 1640, the cells were lysed in digitonin
lysis buffer for 30 min at 0°C . After centrifugation at 13,000 g for 15 min, the lysate was
precleared and immunoprecipitations were carried out using anti-CD3S and anti-ß anti-
serum . The samples were applied to preparative 12% SDS-PAGE gels . After autoradiog-
raphy, gel slices containing the proteins of interest were excised and the proteins were
recovered by electroelution in 5 mM Tris-HCI, 0.1% SDS, pH 7.5, followed by ethanol
precipitation (in the presence of cytochrome C as carrier protein) . Protein pellets were
dissolved in 50% acetic acid and subjected to sequence analysis on a Beckman Model
890M protein sequencer .
Results and Discussion
Although PEER expresses CD3 in association with a 55-60 kD TCR y chain
molecule on the cell surface (Fig . I A) (occasionally a 40 kD protein coprecipitates
in anti-CD3 and anti-TCRy chain precipitates which may represent the S chain
[9]), this cell line is also known to contain an mRNA transcript for the Cß2KONING ET AL.
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constant region of the TCR (8, 11). To investigate if TCR fl chain protein was
expressed in the PEER cell line, PEER cells were either surface labeled with "5I
or biosynthetically labeled with ["S]Met/Cys and subsequently lysed in digitonin
lysis buffer (which has been demonstrated not to interfere with the association
of CD3 and the TCR complex). Immunoprecipitations were carried out using
normal rabbit serum (C), an anti-TCR fl chain antiserum (anti-,B) and an anti-
CD38 antiserum (anti-CD38) (10). Theanti-CD38antiserum precipitated CD3 in
association with the 55-60 kD TCR y chain from '25I-labeled cells (Fig. I B),
whereas it precipitated CD3 in association with a 38 kD molecule from 35S_
labeled cells (Fig. I B). The anti-,B antiserum, which failed to specifically react
with any surface molecules from i25I-labeled cells (Fig. 1B), also detected a 38
kD molecule in the s5S-labeled cells (Fig. 1 B). The reactivity ofboth antipeptide
antisera could be inhibited by the addition ofthe relevant peptides (not shown).
It was next ofinterest to determine whether the 38 kD protein that associated
with CD3 intracellularly was a precursor to the y chain associated with CD3 on
the cell surface, or whether it was the 38 kD protein detectable intracellularly
with the anti-,8 reagent. N-glycanase treatment (Genzyme, Boston, MA) of an
anti-# chain and an anti-CD38 immunoprecipitate reduced the 38 kD proteins
in each to 32 kD (not shown). Furthermore, preclearing of a s5S-labeled lysate
of PEER cells with the anti-,B antiserum completely removed coprecipitation of
the 38 kD band in the anti-CD38 precipitate (Fig. 2). In contrast, preclearing
with the anti CD38 antiserum only partially removed anti-,# reactivity (Fig. 2),
indicating that the majority ofthe ,Bchain protein exists freeofthe CD3 complex.
These results indicatedthat the 38 kDproteinassociated with CD3 intracellularly
was the ,B chain. Definitive proofthat the CD3-associated molecule is the TCR #
chain was obtained by amino acid sequence analysis. The 38 kD bands precipi-
tated with the anti-0 and coprecipitated with the anti-CD38 antisera were isolated
from cell lysates labeled with [sH]Leu and
[31S]Met. Both proteins were found
to have Leu at positions 9, 19, and 25, and Met at positions 11, 13, and 30 (Fig.
3). This sequence (with the exception of Leu at position 25) matches that
described for TCR V07.1 (12), and indicates that in PEER V,Q7.1 rearranged to
C,Q2 (11).
These results clearlyshow that theintracellular CD3-associated 38 kDmolecule
is a TCR ,B chain. Moreover, analysis of TCR chain mRNAs demonstrated that
PEER contains a full-length transcript (1.3 kb) for TCR ,B chain, and confirmed
previous results that this cell line expressed no TCR a chain mRNA but contains
abundant, full-length TCR y chain mRNA (not shown). Therefore, these results
indicate that in PEER free # chainassociateswith theCD3 complex intracellularly
in the absence ofa chain, and suggest that the CD3-TCR# chain complex is not
transported to the cell surface due to the absence of a chain protein. These
results support previous suggestions that immature Tcell lines lack TCR expres-
sion due to the absence of a chain protein (13).
After biosynthetic labeling, we were unable to detect CD3 in association with
the TCR y chain (oritsprecursor) even though free intracellular CD3 isavailable.
This free intracellular CD3 is evident after preclearing with the anti-,B antiserum
(Fig. 2). This indicates that only a minor fraction (presently undetectable) of the
intracellular CD3 complex associates with the TCR y chain (or its precursor).
During murine thymic ontogeny, the yand,8genes are found to be rearranged598
￿
KONING ET AL.
￿
BRIEF DEFINITIVE REPORT
FIGURE 2 .
￿
Sequential immunoprecipitations from 55S-labeled lysates of PEER cells . PEER
cells were metabolically labeled with [ 35S]Met and [95S]Cys and lysed in digitonin lysis buffer .
After preclearing with either normal rabbit serum, anti-S or anti-CD3S, immunoprecipitations
were carried out in these precleared samples with normal rabbit serum (lanes 1), anti-IS (lanes
2) and anti-CD3S (lanes 3) .
and transcribed several days before the a gene (6) . This observation has led to
the speculation that initially the ,3 and y gene products can associate to form a
/3y TCR that, after a gene rearrangement and transcription, is displaced by an
a,3 TCR (6, 7) . However, our observation that, in PEER, CD3-TCR,3 and CD3-
TCRy complexes are formed independently, without any evidence for a ,37
TCR, argues against formation of such a ,3y TCR. This would be compatible
with the notion that the TCRy and ,B chain bind to the same CD3 chain . Both
human and murine TCR ,B and y chains have a conserved positively charged
lysine residue in their transmembrane region (14), which may play a role in
stabilizing the CD3-TCR complex through formation of a salt bridge with the
negatively charged amino acids found in the transmembrane regions of the CD3
subunits (14) . Because the primary association between TCR (a,3) and CD3 (y,
S, and e) appears to be with TCR,3-CD3y (15), the TCR 0 and y chains might
compete for binding to CD3y . At present it is not clear whether thymocytesKONING ET AL.
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FIGURE 3.
￿
Partial NH2-terminalaminoacid sequence of ['H]Leuand ["S]Met-labeled PEER
fl chainandCD3-associated 38 kD molecule. PEER cells were metabolicallylabeled with ['SS]-
Met and ['H]Leu. From these cells, the 38 kD TCR # chain and the 38 kD CD3-associated
proteins were isolated, anda partial NHs-terminal aminoacid sequence wasdetermined. Top:
38 kD TCR ,B chain. Bottom: CD3-associated 38 kD protein.
expressing yS TCR form a separate lineage or that (part of) these thymocytes
switch to a# TCR during maturation. In the latter case, the PEER cell line might
represent a transitional stage.
Summary
We have demonstrated that the PEER cell line, which expresses a CD3-
associated TCR y chain on the cell surface, synthesizes TCR ,B chain intracellu-
larly. A percentage of this TCR ,B chain associates with the CD3 complex
intracellularly. These results indicate that TCR ,B and y chains can be synthesized
by one cell line, and that these chains can independently associate with the CD3
complex. However, the results argue against the formation of TCR 07 chain
complexes in this cell line.
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